Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$13.12 USD
+0.19 (1.50%)
Updated May 13, 2024 01:59 PM ET
1-Strong Buy of 5 1
B Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.12 USD
+0.19 (1.50%)
Updated May 13, 2024 01:59 PM ET
1-Strong Buy of 5 1
B Value B Growth C Momentum B VGM
Zacks News
Wall Street Analysts Believe Green Thumb Industries Inc. (GTBIF) Could Rally 42.3%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Green Thumb Industries Inc. (GTBIF) points to a 42.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
LeMaitre (LMAT) delivered earnings and revenue surprises of 12.82% and 3.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Green Thumb Industries Inc. (GTBIF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Green Thumb Industries Inc. (GTBIF) Misses Q4 Earnings Estimates
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -80% and 3.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Cannabis ETFs: What's Behind the Latest Surge
by Neena Mishra
While marijuana ETFs have seen a recent surge, investors should be aware of the potential risks
Strength Seen in Green Thumb Industries Inc. (GTBIF): Can Its 10.6% Jump Turn into More Strength?
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Inside the Best-Performing ETF of Q3
by Sweta Killa
Roundhill Cannabis ETF (WEED) topped the list of the best-performing ETFs of the third quarter with impressive returns of about 49%.
Cannabis Stocks & ETFs: Can the Recent Surge Continue?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Zacks Investment Ideas feature highlights: Canopy Growth, Green Thumb Industries, Tilray Brands and Innovative Industrial Properties
by Zacks Equity Research
Canopy Growth, Green Thumb Industries, Tilray Brands and Innovative Industrial Properties are part of the Zacks Investment Ideas article.
Time to Get High on Pot Stocks? (3 Catalysts)
by Andrew Rocco
When it comes to marijuana, a significant disconnect exists between the US government and the American people. Stock Strategist Andrew Rocco explains why the worst may be over for marijuana investors.
Green Thumb Industries Inc. (GTBIF) Q2 Earnings Lag Estimates
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -16.67% and 0.64%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Green Thumb Industries Inc. (GTBIF) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -33.33% and 0.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Stryker (SYK) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Stryker (SYK) delivered earnings and revenue surprises of 7% and 4.91%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Ideas feature highlights: Canopy Growth, Green Thumb Industries and AdvisorShares Pure US Cannabis ETF
by Zacks Equity Research
Canopy Growth, Green Thumb Industries and AdvisorShares Pure US Cannabis ETF have been highlighted in this Investment Ideas article.
Pot Stocks Surge on SAFE Banking Act Reintroduction
by Bryan Hayes
Lawmakers are attempting to make a final push toward delivering financial services for the cannabis industry.
Green Thumb Industries Inc. (GTBIF) Q4 Earnings Lag Estimates
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -28.57% and 1.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
AtriCure (ATRC) delivered earnings and revenue surprises of 50% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Green Thumb Industries Inc. (GTBIF) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Green Thumb Industries Inc. (GTBIF) Soars 30.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
GrowGeneration (GRWG) Opens 1st Hydroponic Store in Virginia
by Zacks Equity Research
GrowGeneration (GRWG) opens a new store in Virginia and signs two new leases in New Jersey and Missouri, progressing well on its strategy to grow its retail presence across North America.
Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Green Thumb Industries Inc. (GTBIF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.